{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Phytochemicals", "biomarkers", "kinase", "linalool", "lung cancer", "terpenoids"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34503432", "DateCompleted": {"Year": "2022", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "22"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.2174/1871530321666210909165426"], "Journal": {"ISSN": "2212-3873", "JournalIssue": {"Volume": "22", "Issue": "14", "PubDate": {"Year": "2022"}}, "Title": "Endocrine, metabolic & immune disorders drug targets", "ISOAbbreviation": "Endocr Metab Immune Disord Drug Targets"}, "ArticleTitle": "Exploration of Chemopreventive Potential of Linalool in Targeting Lung Cancer Biomarkers.", "Pagination": {"StartPage": "1416", "EndPage": "1424", "MedlinePgn": "1416-1424"}, "Abstract": {"AbstractText": ["Phytochemicals are used to treat lung cancer in contemporary and traditional medicine. The limitations of known chemotherapeutic drugs such as non-specificity, resistance, and toxicity restrict their use for lung cancer treatment. Therefore, the search for target-specific novel entities is required continuously.", "Linalool, a monoterpene alcohol that possesses antiviral, anti-inflammatory, and antibacterial properties, is present in sweet basil, laurel, jasmine, rosewood, and lavender. Previous reports revealed its anticancer potential against colon, breast, and liver cancer. In this study, linalool's efficacy in targeting biomarkers associated with different lung cancer stages has been investigated.", "The in silico molecular docking analysis was used to explore drug-receptor interaction, and further, linalools cytotoxicity potential was evaluated on lung adenocarcinoma cell line (A549). The toxicity profiling of linalool was done by ADMET analysis.", "In the results, Linalool revealed an excellent binding affinity with the selected targets. It showed the highest interaction with BRAF with the binding energy of -5.6 kcal/mol. Furthermore, it successfully interacts within the binding pocket of BRAF, similar to its inhibitor (Sorafenib). In MTT analysis, linalool significantly reduces the percent viability IC30 474.94 \u00b1 43.12, 379.33 \u00b1 49.5, and 183.77 \u00b1 66.7 \u03bcM in A549 cell lines for 24, 48, and 72 h, respectively.", "These results concluded that linalool possesses chemopreventive potential against lung cancer by interacting or modulating selected biomarkers associated with a lung cancer diagnosis, progression, and proliferation."], "CopyrightInformation": "Copyright\u00a9 Bentham Science Publishers; For any queries, please email at epub@benthamscience.net."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow- 226015, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "School of Envionmental Science, Jawaharlal Nehru University, New Delhi- 110067, India."}], "LastName": "Singh", "ForeName": "Jyoti", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow- 226015, Uttar Pradesh, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, Uttar Pradesh, India."}], "LastName": "Meena", "ForeName": "Abha", "Initials": "A"}], "GrantList": [{"GrantID": "HCP-010", "Agency": "Phytopharma Mission", "Country": ""}, {"GrantID": "GAP-394", "Agency": "CST-UP, Lucknow, India", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United Arab Emirates", "MedlineTA": "Endocr Metab Immune Disord Drug Targets", "NlmUniqueID": "101269157", "ISSNLinking": "1871-5303"}, "ChemicalList": [{"RegistryNumber": "D81QY6I88E", "NameOfSubstance": "linalool"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers, Tumor"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins B-raf"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Biomarkers, Tumor"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Proto-Oncogene Proteins B-raf"}, {"QualifierName": [], "DescriptorName": "Lung Neoplasms"}, {"QualifierName": [], "DescriptorName": "Lung"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bade B.C.; Dela Cruz C.S.; Lung Cancer 2020: Epidemiology, Etiology, and Prevention. Clin Chest Med 2020,41(1),1-24", "ArticleIdList": ["10.1016/j.ccm.2019.10.001", "32008623"]}, {"Citation": "de Mello R.A.; Amaral G.A.; Biomarkers for non-small cell lung cancer: from the bench to the bedside. J Clin Med 2020,9(10),E3376", "ArticleIdList": ["10.3390/jcm9103376", "33096867"]}, {"Citation": "Molina J.R.; Yang P.; Cassivi S.D.; Schild S.E.; Adjei A.A.; Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008,83(5),584-594", "ArticleIdList": ["10.1016/S0025-6196(11)60735-0", "18452692"]}, {"Citation": "Zappa C.; Mousa S.A.; Non-small cell lung cancer: current treatment and future advances. Transl Lung Cancer Res 2016,5(3),288-300", "ArticleIdList": ["10.21037/tlcr.2016.06.07", "27413711"]}, {"Citation": "Demedts I.K.; Vermaelen K.Y.; van Meerbeeck J.P.; Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur Respir J 2010,35(1),202-215", "ArticleIdList": ["10.1183/09031936.00105009", "20044461"]}, {"Citation": "Tang Y.; Qiao G.; Xu E.; Xuan Y.; Liao M.; Yin G.; Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. OncoTargets Ther 2017,10,4527-4534", "ArticleIdList": ["10.2147/OTT.S142149", "28979144"]}, {"Citation": "Burotto M.; Chiou V.L.; Lee J.M.; Kohn E.C.; The MAPK pathway across different malignancies: a new perspective. Cancer 2014,120(22),3446-3456", "ArticleIdList": ["10.1002/cncr.28864", "24948110"]}, {"Citation": "Castellano E.; Downward J.; RAS interaction with PI3K: more than just another effector pathway. Genes Cancer 2011,2(3),261-274", "ArticleIdList": ["10.1177/1947601911408079", "21779497"]}, {"Citation": "Liu P.; Cheng H.; Roberts T.M.; Zhao J.J.; Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009,8(8),627-644", "ArticleIdList": ["10.1038/nrd2926", "19644473"]}, {"Citation": "Li L.; Zhao G.D.; Shi Z.; Qi L.L.; Zhou L.Y.; Fu Z.X.; The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett 2016,12(5),3045-3050", "ArticleIdList": ["10.3892/ol.2016.5110", "27899961"]}, {"Citation": "Chappell W.H.; Steelman L.S.; Long J.M.; Kempf R.C.; Abrams S.L.; Franklin R.A.; B\u00e4secke J.; Stivala F.; Donia M.; Fagone P.; Malaponte G.; Mazzarino M.C.; Nicoletti F.; Libra M.; Maksimovic-Ivanic D.; Mijatovic S.; Montalto G.; Cervello M.; Laidler P.; Milella M.; Tafuri A.; Bonati A.; Evangelisti C.; Cocco L.; Martelli A.M.; McCubrey J.A.; Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011,2(3),135-164", "ArticleIdList": ["10.18632/oncotarget.240", "21411864"]}, {"Citation": "Zhang Y.J.; Gan R.Y.; Li S.; Zhou Y.; Li A.N.; Xu D.P.; Li H.B.; Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 2015,20(12),21138-21156", "ArticleIdList": ["10.3390/molecules201219753", "26633317"]}, {"Citation": "Forni C.; Facchiano F.; Bartoli M.; Pieretti S.; Facchiano A.; D\u2019Arcangelo D.; Norelli S.; Valle G.; Nisini R.; Beninati S.; Tabolacci C.; Jadeja R.N.; Beneficial role of phytochemicals on oxidative stress and age-related diseases. BioMed Res Int 2019,2019,8748253", "ArticleIdList": ["10.1155/2019/8748253", "31080832"]}, {"Citation": "Unuofin J.O.; Lebelo S.L.; Antioxidant effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: an updated review. Oxid Med Cell Longev 2020,2020,1356893", "ArticleIdList": ["10.1155/2020/1356893", "32148647"]}, {"Citation": "Maione F.; Cicala C.; Musciacco G.; De Feo V.; Amat A.G.; Ialenti A.; Mascolo N.; Phenols, alkaloids and terpenes from medicinal plants with antihypertensive and vasorelaxant activities. A review of natural products as leads to potential therapeutic agents. Nat Prod Commun 2013,8(4),539-544", "ArticleIdList": ["10.1177/1934578X1300800434", "23738474"]}, {"Citation": "Kozio\u0142 A.; Stryjewska A.; Librowski T.; Sa\u0142at K.; Gawe\u0142 M.; Moniczewski A.; Lochy\u0144ski S.; An overview of the pharmacological properties and potential applications of natural monoterpenes. Mini Rev Med Chem 2014,14(14),1156-1168", "ArticleIdList": ["10.2174/1389557514666141127145820", "25429661"]}, {"Citation": "Mujeeb F.; Bajpai P.; Pathak N.; Phytochemical evaluation, antimicrobial activity, and determination of bioactive components from leaves of Aegle marmelos. BioMed Res Int 2014,2014,497606", "ArticleIdList": ["10.1155/2014/497606", "24900969"]}, {"Citation": "de C\u00e1ssia da Silveira e S\u00e1 R.; Andrade L.N.; de Sousa D.P.; A review on anti-inflammatory activity of monoterpenes. Molecules 2013,18(1),1227-1254", "ArticleIdList": ["10.3390/molecules18011227", "23334570"]}, {"Citation": "Sharifi-Rad J.; Sureda A.; Tenore G.C.; Daglia M.; Sharifi-Rad M.; Valussi M.; Tundis R.; Sharifi-Rad M.; Loizzo M.R.; Ademiluyi A.O.; Sharifi-Rad R.; Ayatollahi S.A.; Iriti M.; Biological activities of essential oils: from plant chemoecology to traditional healing systems. Molecules 2017,22(1),E70", "ArticleIdList": ["10.3390/molecules22010070", "28045446"]}, {"Citation": "Moon J.H.; Watanabe N.; Ijima Y.; Yagi A.; Sakata K.; Cis- and trans-linalool 3,7-oxides and methyl salicylate glycosides and (Z)-3-hexenyl beta-D-glucopyranoside as aroma precursors from tea leaves for oolong tea. Biosci Biotechnol Biochem 1996,60(11),1815-1819", "ArticleIdList": ["10.1271/bbb.60.1815", "8987857"]}, {"Citation": "Magnard J.L.; Bony A.R.; Bettini F.; Campanaro A.; Blerot B.; Baudino S.; Jullien F.; Linalool and linalool nerolidol synthases in roses, several genes for little scent. Plant Physiol Biochem 2018,127,74-87", "ArticleIdList": ["10.1016/j.plaphy.2018.03.009", "29550664"]}, {"Citation": "Silva L.L.; Balconi L.S.; Gressler L.T.; Garlet Q.I.; Sutili F.J.; Vargas A.P.C.; Baldisserotto B.; Morel A.F.; Heinzmann B.M.; S-(+)- and R-(-)-linalool: a comparison of the in vitro anti-Aeromonas hydrophila activity and anesthetic properties in fish. An Acad Bras Cienc 2017,89(1),203-212", "ArticleIdList": ["10.1590/0001-3765201720150643", "28423080"]}, {"Citation": "Pereira I.; Severino P.; Santos A.C.; Silva A.M.; Souto E.B.; Linalool bioactive properties and potential applicability in drug delivery systems. Colloids Surf B Biointerfaces 2018,171,566-578", "ArticleIdList": ["10.1016/j.colsurfb.2018.08.001", "30098535"]}, {"Citation": "Celik S.; Ozkaya A.; Effects of intraperitoneally administered lipoic acid, vitamin E, and linalool on the level of total lipid and fatty acids in guinea pig brain with oxidative stress induced by HO. J Biochem Mol Biol 2002,35(6),547-552", "ArticleIdList": ["12470587"]}, {"Citation": "Orchard A.; van Vuuren S.; Commercial Essential Oils as Potential Antimicrobials to Treat Skin Diseases. Evid Based Complement Alternat Med 2017,2017,4517971", "ArticleIdList": ["10.1155/2017/4517971", "28546822"]}, {"Citation": "Bickers D.; Calow P.; Greim H.; Hanifin J.M.; Rogers A.E.; Saurat J.H.; Sipes I.G.; Smith R.L.; Tagami H.; A toxicologic and dermatologic assessment of linalool and related esters when used as fragrance ingredients. Food Chem Toxicol 2003,41(7),919-942", "ArticleIdList": ["10.1016/S0278-6915(03)00016-4", "12804649"]}, {"Citation": "Prashar A.; Locke I.C.; Evans C.S.; Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif 2004,37(3),221-229", "ArticleIdList": ["10.1111/j.1365-2184.2004.00307.x", "15144499"]}, {"Citation": "Iwasaki K.; Zheng Y.W.; Murata S.; Ito H.; Nakayama K.; Kurokawa T.; Sano N.; Nowatari T.; Villareal M.O.; Nagano Y.N.; Isoda H.; Matsui H.; Ohkohchi N.; Anticancer effect of linalool via cancer-specific hydroxyl radical generation in human colon cancer. World J Gastroenterol 2016,22(44),9765-9774", "ArticleIdList": ["10.3748/wjg.v22.i44.9765", "27956800"]}, {"Citation": "Pan W.; Zhang G.; Linalool monoterpene exerts potent antitumor effects in OECM 1 human oral cancer cells by inducing sub-G1 cell cycle arrest, loss of mitochondrial membrane potential and inhibition of PI3K/AKT biochemical pathway. J BUON 2019,24(1),323-328", "ArticleIdList": ["30941988"]}, {"Citation": "Rodenak-Kladniew B.; Castro A.; St\u00e4rkel P.; De Saeger C.; Garc\u00eda de Bravo M.; Crespo R.; Linalool induces cell cycle arrest and apoptosis in HepG2 cells through oxidative stress generation and modulation of Ras/MAPK and Akt/mTOR pathways. Life Sci 2018,199,48-59", "ArticleIdList": ["10.1016/j.lfs.2018.03.006", "29510199"]}, {"Citation": "Chang M.Y.; Shieh D.E.; Chen C.C.; Yeh C.S.; Dong H.P.; Linalool induces cell cycle arrest and apoptosis in leukemia cells and cervical cancer cells through CDKIs. Int J Mol Sci 2015,16(12),28169-28179", "ArticleIdList": ["10.3390/ijms161226089", "26703569"]}, {"Citation": "Ravizza R.; Gariboldi M.B.; Molteni R.; Monti E.; Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. Oncol Rep 2008,20(3),625-630", "ArticleIdList": ["18695915"]}, {"Citation": "Naqsh e Zahra S.; Khattak N.A.; Mir A.; Comparative modeling and docking studies of p16ink4/cyclin D1/Rb pathway genes in lung cancer revealed functionally interactive residue of RB1 and its functional partner E2F1. Theor Biol Med Model 2013,10,1", "ArticleIdList": ["10.1186/1742-4682-10-1", "23276293"]}, {"Citation": "Sharma V.; Sharma P.C.; Kumar V.; In silico molecular docking analysis of natural pyridoacridines as anticancer agents. Adv Chem 2016, Article ID 5409387."}, {"Citation": "Villalobos P.; Wistuba I.I.; Lung cancer biomarkers. Hematol Oncol Clin North Am 2017,31(1),13-29", "ArticleIdList": ["10.1016/j.hoc.2016.08.006", "27912828"]}, {"Citation": "Wang S.; Niu X.; Bao X.; Wang Q.; Zhang J.; Lu S.; Wang Y.; Xu L.; Wang M.; Zhang J.; The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging. Oncol Rep 2019,41(5),2636-2646", "ArticleIdList": ["10.3892/or.2019.7080", "30896825"]}, {"Citation": "Tsay J.J.; Wu B.G.; Badri M.H.; Clemente J.C.; Shen N.; Meyn P.; Li Y.; Yie T-A.; Lhakhang T.; Olsen E.; Murthy V.; Michaud G.; Sulaiman I.; Tsirigos A.; Heguy A.; Pass H.; Weiden M.D.; Rom W.N.; Sterman D.H.; Bonneau R.; Blaser M.J.; Segal L.N.; Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am J Respir Crit Care Med 2018,198(9),1188-1198", "ArticleIdList": ["10.1164/rccm.201710-2118OC", "29864375"]}, {"Citation": "Tang Z.; Yu W.; Zhang C.; Zhao S.; Yu Z.; Xiao X.; Tang R.; Xuan Y.; Yang W.; Hao J.; Xu T.; Zhang Q.; Huang W.; Deng W.; Guo W.; CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. Mol Oncol 2016,10(2),317-329", "ArticleIdList": ["10.1016/j.molonc.2015.10.015", "26628108"]}, {"Citation": "Lee S.; Rauch J.; Kolch W.; Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity. Int J Mol Sci 2020,21(3),1102", "ArticleIdList": ["10.3390/ijms21031102", "32046099"]}, {"Citation": "Yang J.; Nie J.; Ma X.; Wei Y.; Peng Y.; Wei X.; Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer 2019,18(1),26", "ArticleIdList": ["10.1186/s12943-019-0954-x", "30782187"]}, {"Citation": "Girija C.R.; Karunakar P.; Poojari C.S.; Begum N.S.; Syed A.A.; Molecular docking studies of curcumin derivatives with multiple protein targets for procarcinogen activating enzyme inhibition. J Proteomics Bioinform 2010,03(06),200-203", "ArticleIdList": ["10.4172/jpb.1000140"]}, {"Citation": "Berman H.M.; Westbrook J.; Feng Z.; Gilliland G.; Bhat T.N.; Weissig H.; Shindyalov I.N.; Bourne P.E.; The protein data bank. Nucleic Acids Res 2000,28(1),235-242", "ArticleIdList": ["10.1093/nar/28.1.235", "10592235"]}, {"Citation": "Alam S.; Khan F.; Virtual screening, Docking, ADMET and system pharmacology studies on Garcinia caged Xanthone derivatives for anticancer activity. Sci Rep 2018,8(1),5524", "ArticleIdList": ["10.1038/s41598-018-23768-7", "29615704"]}, {"Citation": "Kalani K.; Agarwal J.; Alam S.; Khan F.; Pal A.; Srivastava S.K.; Srivastava S.K.; In silico and in vivo anti-malarial studies of 18\u03b2 glycyrrhetinic acid from Glycyrrhiza glabra. PLoS One 2013,8(9),e74761", "ArticleIdList": ["10.1371/journal.pone.0074761", "24086367"]}, {"Citation": "Trott O.; Olson A.J.; AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010,31(2),455-461", "ArticleIdList": ["19499576"]}, {"Citation": "Morr\u00e9 D.J.; Sun E.; Geilen C.; Wu L.Y.; de Cabo R.; Krasagakis K.; Orfanos C.E.; Morr\u00e9 D.M.; Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 1996,32A(11),1995-2003", "ArticleIdList": ["10.1016/0959-8049(96)00234-1", "8943687"]}, {"Citation": "Forli S.; Huey R.; Pique M.E.; Sanner M.F.; Goodsell D.S.; Olson A.J.; Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nat Protoc 2016,11(5),905-919", "ArticleIdList": ["10.1038/nprot.2016.051", "27077332"]}, {"Citation": "Lipinski C.A.; Lombardo F.; Dominy B.W.; Feeney P.J.; Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001,46(1-3),3-26", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Ertl P.; Rohde B.; Selzer P.; Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000,43(20),3714-3717", "ArticleIdList": ["10.1021/jm000942e", "11020286"]}, {"Citation": "Berridge MV; Herst PM; Tan AS; Tetrazolium dyes as tools in cell biology: New insights into their cellular reduction. 2005,11,127-152"}, {"Citation": "Singh S.; Dubey V.; Singh D.K.; Fatima K.; Ahmad A.; Luqman S.; Antiproliferative and antimicrobial efficacy of the compounds isolated from the roots of Oenothera biennis L. J Pharm Pharmacol 2017,69(9),1230-1243", "ArticleIdList": ["10.1111/jphp.12753", "28555835"]}, {"Citation": "Guimar\u00e3es A.C.; Meireles L.M.; Lemos M.F.; Guimar\u00e3es M.C.C.; Endringer D.C.; Fronza M.; Scherer R.; Antibacterial activity of terpenes and terpenoids present in essential oils. Molecules 2019,24(13),E2471", "ArticleIdList": ["10.3390/molecules24132471", "31284397"]}, {"Citation": "Hamzeh S.; Safari-Faramani R.; Khatony A.; Effects of aromatherapy with lavender and peppermint essential oils on the sleep quality of cancer patients: a randomized controlled trial. Evid Based Complement Alternat Med 2020,2020,7480204", "ArticleIdList": ["10.1155/2020/7480204", "32308715"]}, {"Citation": "Usta J.; Kreydiyyeh S.; Knio K.; Barnabe P.; Bou-Moughlabay Y.; Dagher S.; Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels. Chem Biol Interact 2009,180(1),39-46", "ArticleIdList": ["10.1016/j.cbi.2009.02.012", "19428344"]}, {"Citation": "Xing X.; Ma J.H.; Fu Y.; Zhao H.; Ye X.X.; Han Z.; Jia F.J.; Li X.; Essential oil extracted from Erythrina corallodendron L. leaves inhibits the proliferation, migration, and invasion of breast cancer cells. Medicine (Baltimore) 2019,98(36),e17009", "ArticleIdList": ["10.1097/MD.0000000000017009", "31490383"]}, {"Citation": "Gustafson AM; Soldi R; Anderlind C; Scholand MB; Qian J; Zhang X; Cooper K; Walker D; McWilliams A; Liu G; Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci Translat Med 2010,2(26),26ra25", "ArticleIdList": ["10.1126/scitranslmed.3000251"]}, {"Citation": "Tomasini P.; Walia P.; Labbe C.; Jao K.; Leighl N.B.; Targeting the KRAS pathway in non-small cell lung cancer. Oncologist 2016,21(12),1450-1460", "ArticleIdList": ["10.1634/theoncologist.2015-0084", "27807303"]}, {"Citation": "O\u2019Leary C.G.; Andelkovic V.; Ladwa R.; Pavlakis N.; Zhou C.; Hirsch F.; Richard D.; O\u2019Byrne K.; Targeting BRAF mutations in non-small cell lung cancer. Transl Lung Cancer Res 2019,8(6),1119-1124", "ArticleIdList": ["10.21037/tlcr.2019.10.22", "32010589"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "2"}, {"Year": "2021", "Month": "6", "Day": "26"}, {"Year": "2021", "Month": "6", "Day": "29"}, {"Year": "2021", "Month": "9", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "10", "Hour": "5", "Minute": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34503432", "10.2174/1871530321666210909165426", "EMIDDT-EPUB-117816"]}}], "PubmedBookArticle": []}